Genpharm ULC
6
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects
Role: collaborator
Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State
Role: collaborator
Comparative Bioavailability Study of Clarithromycin 250 mg Tablets
Role: collaborator
Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects
Role: collaborator
Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State
Role: collaborator
Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
Role: collaborator
All 6 trials loaded